SU‐E‐T‐414: TG‐129 Implementation On BrachyvisionTM
A Nguyen(Ironwood Pharmaceuticals (United States)), Christopher Yang(California Institute of Technology), M.R. Kanakamedala(Jackson Memorial Hospital), Yu‐Feng Hu(Albert Einstein College of Medicine), Jennifer Ma(Jackson Memorial Hospital), Rui He(Southwest General Health Center), S. Packianathan(Jackson Memorial Hospital), Paul Mobit(Jackson Memorial Hospital), T.J. Paul(Ironwood Pharmaceuticals (United States)), A Plowman(American Society for Photogrammetry and Remote Sensing)
Cited by 0
Related Papers
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
|Circulation|2018|221
Meeting an 80% reduction in greenhouse gas emissions from transportation by 2050: A case study in California
|Transportation Research Part D Transport and Environment|2009|204
Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation
|Journal of the American College of Cardiology|2014|174
F<scp>UEL</scp> C<scp>ELLS</scp>: Reaching the Era of Clean and Efficient Power Generation in the Twenty-First Century
|Annual Review of Energy and the Environment|1999|167